Dr Justin Charland, DPT | |
12 Booth Dr, Plattsburgh, NY 12901-6404 | |
(518) 561-2225 | |
Not Available |
Full Name | Dr Justin Charland |
---|---|
Gender | Male |
Speciality | Physical Therapy |
Experience | 12 Years |
Location | 12 Booth Dr, Plattsburgh, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235487562 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 035392 (New York) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Pearl Physical Therapy, Pc | 7719029958 | 3 |
News Archive
The American Cancer Society (ACS), the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology (ASCP) have released new guidelines for the prevention and early detection of cervical cancer.
A recent survey of nurses from seven European countries, published in the peer-reviewed journal ecancermedicalscience, has analysed the management of patients suffering from toxicities due to treatment with epidermal growth factor receptor inhibitors.
A British nanotech company has created a potentially life-changing technology that aims to overcome the global crisis of antibiotic resistance.
Learning the role of immune system cells in healthy digestive tracts and how they interact with neighboring nerve cells may lead to new treatments for irritable bowel syndrome (IBS).
The outcomes of chronic myeloid leukemia (CML) have dramatically improved as the result of tyrosine kinase inhibitor (TKI) treatment. Use of a TKI regimen can lower the blood CML biomarker to levels imperceptible by current detection methods. For patients in "molecular remission," however, uncertainties remain regarding whether they will relapse or if treatment should be discontinued.
› Verified 3 days ago
Provider Name | Pearl Physical Therapy, Pc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1669706750 PECOS PAC ID: 7719029958 Enrollment ID: O20100126000440 |
News Archive
The American Cancer Society (ACS), the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology (ASCP) have released new guidelines for the prevention and early detection of cervical cancer.
A recent survey of nurses from seven European countries, published in the peer-reviewed journal ecancermedicalscience, has analysed the management of patients suffering from toxicities due to treatment with epidermal growth factor receptor inhibitors.
A British nanotech company has created a potentially life-changing technology that aims to overcome the global crisis of antibiotic resistance.
Learning the role of immune system cells in healthy digestive tracts and how they interact with neighboring nerve cells may lead to new treatments for irritable bowel syndrome (IBS).
The outcomes of chronic myeloid leukemia (CML) have dramatically improved as the result of tyrosine kinase inhibitor (TKI) treatment. Use of a TKI regimen can lower the blood CML biomarker to levels imperceptible by current detection methods. For patients in "molecular remission," however, uncertainties remain regarding whether they will relapse or if treatment should be discontinued.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Justin Charland, DPT 12 Booth Dr, Plattsburgh, NY 12901-6404 Ph: () - | Dr Justin Charland, DPT 12 Booth Dr, Plattsburgh, NY 12901-6404 Ph: (518) 561-2225 |
News Archive
The American Cancer Society (ACS), the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology (ASCP) have released new guidelines for the prevention and early detection of cervical cancer.
A recent survey of nurses from seven European countries, published in the peer-reviewed journal ecancermedicalscience, has analysed the management of patients suffering from toxicities due to treatment with epidermal growth factor receptor inhibitors.
A British nanotech company has created a potentially life-changing technology that aims to overcome the global crisis of antibiotic resistance.
Learning the role of immune system cells in healthy digestive tracts and how they interact with neighboring nerve cells may lead to new treatments for irritable bowel syndrome (IBS).
The outcomes of chronic myeloid leukemia (CML) have dramatically improved as the result of tyrosine kinase inhibitor (TKI) treatment. Use of a TKI regimen can lower the blood CML biomarker to levels imperceptible by current detection methods. For patients in "molecular remission," however, uncertainties remain regarding whether they will relapse or if treatment should be discontinued.
› Verified 3 days ago
Mrs. Susan H Labarge, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 179 Tom Miller Rd, Plattsburgh, NY 12901 Phone: 518-563-9471 Fax: 518-563-9488 | |
Kathleen Vanness, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 75 Beekman St, Plattsburgh, NY 12901 Phone: 518-562-7900 Fax: 518-562-7933 | |
Mrs. Kellee Bruce Lavalley, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 185 Margaret Street, Suite 1000, Plattsburgh, NY 12985 Phone: 518-561-6361 Fax: 518-561-6367 | |
Brittany Elizabeth Bense, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 22 New York Rd, Plattsburgh, NY 12903 Phone: 518-561-3803 | |
Mrs. Shawn Catherine Bibeau, M.S.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 279 New York Rd, Plattsburgh, NY 12903 Phone: 518-324-8180 | |
Heather Fehlner, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 176 Us Oval, Plattsburgh, NY 12903 Phone: 518-565-7771 | |
Cory A Bilow, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 176 Tom Miller Rd, Plattsburgh, NY 12901 Phone: 518-562-4616 Fax: 518-562-7918 |